IDEAYA BIOSCIENCES INC (IDYA)
US45166A1025 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 108.34M | 157.02M | 68.60M | 92.00M | 72.00M | |||
| Marketable Securities | 590.43M | 368.10M | 296.20M | 154.70M | 211.50M | |||
| Receivables | 15.00K | 18.00K | 200.00K | 1.10M | 1.90M | |||
| Other Current Assets | 10.57M | 7.50M | 5.40M | 3.10M | 3.10M | |||
| Total Current Assets | 709.35M | 532.63M | 370.50M | 251.00M | 288.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.69M | 8.41M | 9.00M | 8.70M | 9.50M | |||
| Investments And Advances | 242.64M | 107.49M | 8.30M | 121.30M | N/A | |||
| Other Non-Current Assets | 849.00K | 782.00K | 200.00K | 400.00K | 200.00K | |||
| Total Non-Current Assets | 252.17M | 116.68M | 17.50M | 130.30M | 9.70M | |||
| TOTAL ASSETS | 961.53M | 649.32M | 388.00M | 381.30M | 298.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 18.67M | 20.50M | 18.90M | 14.00M | 10.10M | |||
| Accounts Payable | 6.29M | 6.60M | 4.30M | 2.10M | 1.00M | |||
| Other Current Liabilities | N/A | 0.00 | 8.60M | 29.00M | 27.60M | |||
| Total Current Liabilities | 24.96M | 27.10M | 31.70M | 45.20M | 38.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.26M | 1.13M | 6.80M | 34.70M | 61.40M | |||
| Total Non-Current Liabilities | 1.26M | 1.13M | 6.80M | 34.60M | 61.40M | |||
| TOTAL LIABILITIES | 26.22M | 28.23M | 38.50M | 79.80M | 100.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -387.94M | -348.36M | -235.40M | -176.70M | -127.00M | |||
| Additional Paid In Capital | 1.32B | 968.88M | 587.70M | 479.00M | 325.30M | |||
| Common Shares | 7.00K | 7.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -923.00K | 562.00K | -2.90M | -700.00K | 0.00 | |||
| Shares Outstanding | 74.76M | 65.04M | 48.20M | 38.50M | 29.50M | |||
| Tangible Book Value per Share | 12.51 | 9.55 | 7.25 | 7.83 | 6.72 | |||
| Total Shareholders' Equity | 935.31M | 621.09M | 349.50M | 301.50M | 198.30M | |||
| TOTAL LIABILITIES AND EQUITY | 961.53M | 649.32M | 388.00M | 381.30M | 298.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 28.42 | 19.65 | 11.69 | 5.55 | 7.48 | |||
| Return On Assets (ROA) | -13.41% | -17.40% | -15.12% | -13.05% | -11.57% | |||
| Return On Equity (ROE) | -13.78% | -18.19% | -16.78% | -16.50% | -17.40% | |||
All data in USD